LuciAda is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA- approved test, who have received at least one prior systemic therapy.
Ankita Ravishankar Rayamwar (CEO) Pharma Mart H No 1414-A, Block No 19, Near Mahatma Gandhi School, Budhvasi Nagorao Padshankar Marg, Bezanbagh, Jaripatka Nagpur - 440004, Maharashtra, India